WRBY Warby Parker Inc.
Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Warby Parker (NYSE: WRBY)
›
Warby Parker (NYSE: WRBY) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 2,275 employees.
The shares were at 24.13 USD on 19 November 2026, up 42.3% over 52 weeks. Its 52-week range is 16.26 USD to 31.75 USD: the price is 24.0% below the high and 48.4% above the low.
At a market capitalisation of 3.00B USD, it trades at 402.2 times trailing earnings and 38.0 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a premium of 717% for WRBY.
Warby Parker reports return on equity of 0.4%, an operating margin of -0.9% and revenue up 10.4% year over year.
It holds more cash than debt, a net cash position of 23.11M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 32.25 USD is 33.7% above the current price. The next earnings report is expected on 25 February 2027.